Trade RNAC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Cartesian Therapeutics, Inc. (RNAC) is trading at US$7.92, down 1.37% today as of Sep 21, 13:45 EDT. The company has a market capitalisation of US$303.76M. Over the past 52 weeks, RNAC has traded between US$5.60 and US$11.00. On Syfe you can trade RNAC with $0 commission and add it to your watchlist.
| Previous close | US$8.03 |
|---|---|
| Market cap | US$303.76M |
| 52-week range | US$5.60 – US$11.00 |
| Volume | 211.66K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.
Year: 2016
Cartesian Therapeutics Signs Licensing Agreement With WestGene to Develop Therapies for Autoimmune Diseases
Jun 9, 12:42 PM · MT Newswires
Cartesian Therapeutics Secures Up to $150 Million Credit Facility From K2 HealthVentures
May 26, 11:52 AM · MT Newswires
Cartesian Therapeutics, Inc. (RNAC) stock is trading at US$7.92, -1.37% from the previous close of US$8.03.
The market cap for Cartesian Therapeutics, Inc. (RNAC) stock is approximately US$303.76M.
The 52-week high for Cartesian Therapeutics, Inc. (RNAC) stock is US$11.00.
The 52-week low for Cartesian Therapeutics, Inc. (RNAC) stock is US$5.60.
Cartesian Therapeutics, Inc. (RNAC) does not currently pay a dividend.
Stay on top of RNAC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
